Equipe d’Accueil 3544, Laboratoire de Neuropharmacologie, Université Paris-XI, Châtenay-Malabry, France.
Mol Pharmacol. 2012 Feb;81(2):106-12. doi: 10.1124/mol.111.075796. Epub 2011 Oct 26.
Most preclinical studies investigating the effects and the mechanism of action of antidepressants have been performed in naive rodents. This is inappropriate because antidepressants act on specific symptoms of the pathological condition, such as distress and anxiety. We have developed a mouse model of anxiety/depression based on addition of corticosterone to drinking water. This model is highly reproducible and easy to set up compared with unpredictable chronic mild stress. The serotonin 1A (5-HT(1A)) autoreceptor is known to play a role in mood disorders and their treatments. An increase in somatodendritic 5-HT(1A) autoreceptor density in the dorsal raphe (DR) attenuates the therapeutic activity of selective serotonin-reuptake inhibitors (SSRIs), whereas their functional desensitization promotes activation of brain serotonergic transmission, thereby representing an adaptive change relevant to their therapeutic effect. Here we assessed the effects of sustained administration of the SSRI fluoxetine on 5-HT(1A) autoreceptor sensitivity in mice administered with corticosterone. Fluoxetine attenuated hypothermia induced by the 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin, decreased DR 5-HT neuronal activity, and decreased 5-HT release in both vehicle- and corticosterone-pretreated mice. However, such desensitization was more pronounced in corticosterone-pretreated mice. This change had an overall effect on serotonergic tone because we found a greater firing rate of 5-HT neurons associated with an enhancement of 5-HT outflow in the DR of corticosterone-pretreated mice in response to fluoxetine compared with the corresponding group of vehicle-pretreated mice. These results provide cellular explanations for the antidepressant effects produced by SSRIs in subjects with pathological conditions but not in naive animals or healthy volunteers.
大多数研究抗抑郁药作用和作用机制的临床前研究都是在未处理的啮齿动物中进行的。这是不合适的,因为抗抑郁药作用于病理状况的特定症状,如痛苦和焦虑。我们已经开发了一种基于在饮用水中添加皮质酮的焦虑/抑郁小鼠模型。与不可预测的慢性轻度应激相比,这种模型具有高度重现性和易于建立的特点。已知 5-羟色胺 1A(5-HT1A)自身受体在情绪障碍及其治疗中起作用。背侧中缝(DR)中 somatodendritic 5-HT1A 自身受体密度的增加会减弱选择性 5-羟色胺再摄取抑制剂(SSRIs)的治疗活性,而其功能脱敏会促进脑 5-羟色胺能传递的激活,从而代表与其治疗效果相关的适应性变化。在这里,我们评估了持续给予 SSRIs 氟西汀对皮质酮处理小鼠中 5-HT1A 自身受体敏感性的影响。氟西汀减弱了 5-HT1A 受体激动剂 8-羟基-2-(二正丙基氨基)四氢萘诱导的体温过低,降低了 DR 5-HT 神经元活性,并降低了两种载体和皮质酮预处理小鼠的 5-HT 释放。然而,这种脱敏在皮质酮预处理的小鼠中更为明显。这种变化对 5-羟色胺能张力具有总体影响,因为我们发现与相应的载体预处理小鼠相比,皮质酮预处理小鼠的 DR 中与 5-HT 神经元放电率增加相关的 5-HT 神经元放电率更高,并且 5-HT 流出增强。响应氟西汀。这些结果为 SSRI 在有病理条件的受试者中产生的抗抑郁作用提供了细胞解释,但在未处理的动物或健康志愿者中则没有。